Organization | Wirghtington Wigan and Leigh NHS Trust

Wirghtington Wigan and Leigh NHS Trust Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial

2010

NCT00973908

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2010

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 3 Trials (9)

bifidobacterium breve (1 trial)

bifidobacterium infantis (1 trial)

bifidobacterium longum (1 trial)

Lactobacillus acidophilus (1 trial)

lactobacillus casei (1 trial)

lactobacillus delbrueckii (1 trial)

lactobacillus plantarum (1 trial)

streptococcus salivarius (1 trial)

vsl #3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Diarrhea (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 1
# of Trial APIs: 9